Radiosensitizing effect of anti-HER2/neu agents: Report of 2 cases and review of the literature

Pract Radiat Oncol. 2015 Mar-Apr;5(2):e61-5. doi: 10.1016/j.prro.2014.06.006. Epub 2014 Jul 25.

Authors

Deborah A Katz¹, Ross A Abrams², Joy S Sclamberg³, Lydia Usha⁴

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, Rush University Medical Center, Chicago, Illinois. Electronic address: deborah_katz@rush.edu.
² Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois.
³ Department of Diagnostic Radiology, Rush University Medical Center, Chicago, Illinois.
⁴ Division of Hematology and Oncology, Department of Medicine, Rush University Medical Center, Chicago, Illinois.

PMID: 25413407
DOI: 10.1016/j.prro.2014.06.006

No abstract available

Publication types

Case Reports
Review

MeSH terms

Adult
Breast Neoplasms / drug therapy*
Breast Neoplasms / enzymology
Breast Neoplasms / pathology
Breast Neoplasms / radiotherapy*
Carcinoma, Ductal, Breast / drug therapy
Carcinoma, Ductal, Breast / enzymology
Carcinoma, Ductal, Breast / radiotherapy
Female
Humans
Neoplasm Metastasis
Radiation-Sensitizing Agents / therapeutic use*
Receptor, ErbB-2 / antagonists & inhibitors*

Substances

Radiation-Sensitizing Agents
ERBB2 protein, human
Receptor, ErbB-2